A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Blueprint Medicines Corporation
Crossbow Therapeutics, Inc.
Theradex
Solu Therapeutics, Inc
Ellipses Pharma
Aptose Biosciences Inc.
Cogent Biosciences, Inc.
Tr1X, Inc.
Epigenetix, Inc.